Gut Microbes,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: Jan. 12, 2025
The
therapeutic
benefits
of
opioids
are
compromised
by
the
development
analgesic
tolerance,
which
necessitates
higher
dosing
for
pain
management
thereby
increasing
liability
drug
dependence
and
addiction.
Rodent
models
indicate
opposing
roles
gut
microbiota
in
tolerance:
morphine-induced
dysbiosis
exacerbates
whereas
probiotics
ameliorate
tolerance.
Not
all
individuals
develop
could
be
influenced
differences
microbiota,
yet
no
study
design
has
capitalized
upon
this
natural
variation.
We
leveraged
behavioral
variation
a
murine
model
voluntary
oral
morphine
self-administration
to
elucidate
mechanisms
influences
Although
mice
shared
similar
morphine-driven
changes
that
largely
masked
informative
associations
with
variability
our
high-resolution
temporal
analyses
revealed
divergence
progression
best
explained
sustained
antinociception.
Mice
did
not
tolerance
maintained
capacity
production
short-chain
fatty
acid
(SCFA)
butyrate
known
bolster
intestinal
barriers
promote
neuronal
homeostasis.
Both
fecal
microbial
transplantation
(FMT)
from
donor
dietary
supplementation
significantly
reduced
independently
suppression
systemic
inflammation.
These
findings
inform
immediate
therapies
extend
efficacy
opioids.
Chinese Medical Journal,
Journal Year:
2023,
Volume and Issue:
137(1), P. 8 - 20
Published: Nov. 30, 2023
Abstract
The
intestine
harbors
a
large
population
of
microorganisms
that
interact
with
epithelial
cells
to
maintain
host
healthy
physiological
status.
These
intestinal
microbiota
engage
in
the
fermentation
non-digestible
nutrients
and
produce
beneficial
metabolites
regulate
homeostasis,
metabolism,
immune
response.
disruption
microbiota,
known
as
dysbiosis,
has
been
implicated
many
diseases,
including
colorectal
cancer
(CRC).
As
third
most
common
second
leading
cause
cancer-related
death
worldwide,
CRC
poses
significant
health
burden.
There
is
an
urgent
need
for
novel
interventions
reduce
incidence
improve
clinical
outcomes.
Modulating
emerged
promising
approach
prevention
treatment.
Current
research
efforts
probiotics
primarily
focus
on
reducing
CRC,
alleviating
treatment-related
side
effects,
potentiating
efficacy
anticancer
therapy,
which
key
successful
translation
practice.
This
paper
aims
review
traditional
new
interventions,
such
next-generation
postbiotics,
context
CRC.
underlying
mechanisms
probiotic
anti-cancer
effects
are
also
discussed,
restoration
microbial
composition,
reinforcement
gut
barrier
integrity,
induction
cell
apoptosis,
inactivation
carcinogens,
modulation
further
evaluates
strategy
adjuvant
therapy
boosting
chemotherapy
immunotherapy.
Despite
all
findings
presented
studies,
evaluation
potential
risks,
optimization
delivery
methods,
consideration
intra-patient
variability
baseline
must
be
thoroughly
interpreted
before
bench-to-bedside
translation.
Critical Reviews in Food Science and Nutrition,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 18
Published: Oct. 16, 2024
Akkermansia
muciniphila
(A.
muciniphila)
has
gained
recognition
as
a
pioneering
probiotic,
exhibiting
considerable
potential
to
enhance
immune
conditions
across
both
humans
and
animals.
The
health
benefits
of
A.
are
attributed
its
various
components,
including
outer
membrane
proteins
(PilQ
Amuc_1100),
secreted
(P9
AmTARS),
extracellular
vesicles,
metabolites
such
SCFAs,
ornithine
lipids,
γ-aminobutyric
acid,
cobalamin,
inosine.
dynamic
control
the
mucus
layer
by
plays
crucial
role
in
regulating
intestinal
mucosal
immunity.
Furthermore,
modulates
function
interacting
with
macrophages,
dendritic
cells,
T
lymphocytes,
Paneth
cells.
Increasing
abundance
gut
through
nutritional
strategies
represents
safe
effective
means
augment
function.
Various
polyphenols,
oligosaccharides,
polysaccharides
have
been
shown
elevate
levels
this
bacterium,
thereby
contributing
favorable
immunoregulatory
outcomes.
This
paper
delves
into
latest
research
advancements
related
probiotic
mechanisms
provides
an
overview
current
understanding
how
responds
nutrients.
These
insights
offer
theoretical
foundation
for
utilization
immunoregulation.
The
gut
microbiome
is
altered
in
MS
and
may
contribute
to
disease
by
disrupting
the
intestinal
barrier.
colonic
mucus
barrier,
which
primarily
composed
of
mucin
protein
2
(MUC2),
plays
a
crucial
role
providing
barrier
between
epithelial
cells
microbiome.
Disruption
barriers
has
been
reported
inflammatory
bowel
(IBD)
Parkinson's
(PD)
but
not
studied
context
multiple
sclerosis
(MS).
We
investigated
tight
junction
zonulin
occludins
1
(ZO-1),
MUC2,
stool
markers
(calprotectin)
microbiota
composition
subjects
with
relapsing
progressive
MS.
MUC2
was
decreased
both
ZO-1
elevated
serum
stool.
Inflammatory
typically
IBD
PD,
including
calprotectin,
were
stool,
suggesting
specificity
physiology
Microbiota
known
degrading
capacity
negatively
correlated
levels.
Taken
together,
these
findings
suggest
reduced
function
linked
increased
bacteria.Funding:
This
work
supported
grants
from
NIH/NINDS
R21NS126866,
NMSS
#FG-2207-
40162,
Nancy
Davis
Race
Erase
Young
Investigator
Award,
Water
Cove
Charitable
Foundation,
Clara
E.
John
H.
Ware
Jr.
Foundation.Declaration
Interest:
None
declare.Ethical
Approval:
All
protocols
approved
BWH
institutional
review
board
(IRB
Protocol
#:
2017P001169)
informed
consent
obtained
every
study
subject.
Gut Microbes,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: Jan. 12, 2025
The
therapeutic
benefits
of
opioids
are
compromised
by
the
development
analgesic
tolerance,
which
necessitates
higher
dosing
for
pain
management
thereby
increasing
liability
drug
dependence
and
addiction.
Rodent
models
indicate
opposing
roles
gut
microbiota
in
tolerance:
morphine-induced
dysbiosis
exacerbates
whereas
probiotics
ameliorate
tolerance.
Not
all
individuals
develop
could
be
influenced
differences
microbiota,
yet
no
study
design
has
capitalized
upon
this
natural
variation.
We
leveraged
behavioral
variation
a
murine
model
voluntary
oral
morphine
self-administration
to
elucidate
mechanisms
influences
Although
mice
shared
similar
morphine-driven
changes
that
largely
masked
informative
associations
with
variability
our
high-resolution
temporal
analyses
revealed
divergence
progression
best
explained
sustained
antinociception.
Mice
did
not
tolerance
maintained
capacity
production
short-chain
fatty
acid
(SCFA)
butyrate
known
bolster
intestinal
barriers
promote
neuronal
homeostasis.
Both
fecal
microbial
transplantation
(FMT)
from
donor
dietary
supplementation
significantly
reduced
independently
suppression
systemic
inflammation.
These
findings
inform
immediate
therapies
extend
efficacy
opioids.